Ilyang Pharmaceutical Co.,Ltd (KRX: 007570)

Ilyang Pharmaceutical Co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	231,667	281,258	349,981	510,655	1,197,901	410,527
Market Cap Growth	-25.91%	-19.64%	-31.46%	-57.37%	191.80%	-17.82%
Enterprise Value	344,892	394,941	436,337	605,360	1,322,774	552,846
Last Close Price	12890.00	15650.00	19161.53	27568.46	64205.98	21960.22
PE Ratio	-	-111.79	18.50	34.90	107.55	40.07
PS Ratio	0.63	0.76	0.91	1.38	3.49	1.26
PB Ratio	1.02	1.07	1.20	1.88	4.89	1.84
P/FCF Ratio	12.28	21.16	13.54	9.44	25.32	12.07
P/OCF Ratio	7.20	14.51	11.69	7.62	20.84	11.34
EV/Sales Ratio	0.94	1.07	1.14	1.63	3.85	1.70
EV/EBITDA Ratio	16.32	10.28	8.16	11.28	28.29	12.98
EV/EBIT Ratio	40.84	15.92	10.80	14.76	38.79	17.00
EV/FCF Ratio	18.28	29.71	16.88	11.19	27.96	16.25
Debt / Equity Ratio	0.36	0.32	0.29	0.38	0.42	0.58
Debt / EBITDA Ratio	2.74	2.22	1.60	1.90	2.20	3.02
Debt / FCF Ratio	5.18	6.40	3.32	1.89	2.18	3.78
Asset Turnover	0.76	0.77	0.77	0.80	0.78	0.75
Inventory Turnover	2.32	2.77	3.28	3.72	3.17	2.83
Quick Ratio	0.49	0.51	0.71	0.76	0.60	0.58
Current Ratio	0.88	0.92	1.07	1.03	0.92	0.95
Return on Equity (ROE)	1.37%	0.04%	11.26%	10.05%	9.21%	9.06%
Return on Assets (ROA)	3.00%	3.24%	5.09%	5.49%	4.86%	4.67%
Return on Capital (ROIC)	3.95%	4.27%	6.72%	7.10%	6.10%	5.76%
Earnings Yield	0.25%	-0.91%	5.50%	2.82%	0.91%	2.43%
FCF Yield	8.15%	4.73%	7.39%	10.60%	3.95%	8.29%
Dividend Yield	1.16%	0.96%	-	-	-	-
Payout Ratio	685.90%	-	20.49%	61.00%	45.05%	58.24%
Buyback Yield / Dilution	0.58%	0.59%	0.44%	-	-	0.29%
Total Shareholder Return	1.74%	1.55%	0.44%	-	-	0.29%

Source: S&P Capital IQ. Standard template. Financial Sources.